HANetf ICAV Harbor Health Care UCITS ETF Acc GBP (WELP)
7.60p
(1.42%)
- Add to watchlist
- Create an alert
- This stock can be held in a
7.60p
(1.42%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
7.60p
(1.42%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
541.20p
544.30p
586.20p
London
536.95p
540.26p
519.40p
$15.82M
4.95p (0.93%) Previous:
4.95p
515
n/a
GBX
ETP Basics
| Issuer: | HANetf ICAV |
|---|---|
| Structure: | ETF |
| Replication method: | Stocks - Full Replication |
| Securities lending: | No |
| Number of holdings: | 43 |
| Size: | $15.8M |
| Launch date: | 04 April 2019 |
| Launch price: | $7.77 |
| UCITS: | Yes |
| Reporting status: | Yes |
| Domicile: | Ireland |
| Complex product: | Non-complex |
| ISIN: | IE00BJQTJ848 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
| Index: | NA |
|---|---|
| Aim: |
The Sub-Fund is actively managed and invests primarily in equity securities, and equity...
Read full aim for HANetf ICAV |
| Leverage: | N/A |
| Currency hedging: | No |
COSTS
| Ongoing Charge (OCF/TER): | 0.89% |
|---|---|
| Management fee: | 0.89% |
| Indicative spread: | 0.24% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
Not available for this stock.
| Security | Weight |
|---|---|
| ASCENDIS PHARMA A/S | 10.04% |
| ABBVIE | 7.80% |
| LEGEND BIOTECH CORP | 7.76% |
| MASIMO CORP | 5.50% |
| PFIZER | 4.78% |
| OPTION CARE HEALTH | 4.48% |
| LANTHEUS HOLDINGS | 4.43% |
| ICON | 4.24% |
| UNITEDHEALTH GROUP INCORPORATED | 3.82% |
| DEXCOM | 3.62% |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.